DOCUZEN
- Product NDC
- 71205-282
- Requested package NDC
- 71205-282-90
- 11-digit product format
- 712050282
- Labeler code
- 71205
- Product ID
- 71205-282_3e549d03-823e-4fbe-935a-e9f7de196abc
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Sennosides 8.6mg and Docusate Sodium 50mg
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Proficient Rx LP
- Application
- M007
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2018-11-27
- Substance
- SENNOSIDES; DOCUSATE SODIUM
- Active strength
- 8.6; 50 mg/1; mg/1
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- DOCUZEN
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| SENNOSIDES | 8.6 mg/1 |
| DOCUSATE SODIUM | 50 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 3FYP5M0IJX | Internal UNII lookup |
| F05Q2T2JA0 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 998740 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 92879e62-f60a-4ab4-9532-610cdd2628ee | Available on FDA.report |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71205-282-30 | DOCUZEN | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | 5 | |
| 71205-282-60 | DOCUZEN | 60 in 1 BOTTLE, PLASTIC | TABLET | 60 | 5 | |
| 71205-282-90 | DOCUZEN | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | 5 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 71205-282-60 | EA - Each | 71205-282 | 36f476f3-c022-4fce-9203-aebc9ed5390e | 1 | 2019-07-02 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| up and up fiber therapy | PSYLLIUM HUSK | TARGET CORPORATION | 956c48f8-c705-4a86-9866-c68a48ddeb6c | 2026-11-06 | Warnings | M007 |
| Sennosides | SENNOSIDES | REMEDYREPACK INC. | 3873abcd-8312-47d1-bccf-4265e1e32861 | 2026-11-06 | Warnings | M007 |
| up and up fiber therapy | PSYLLIUM HUSK | Target Corporation | 674753ee-1174-4c06-9ed3-a090b338a39e | 2026-11-06 | Warnings | M007 |
| up and up fiber therapy Natural Fiber | PSYLLIUM HUSK | Target Corporation | f8b1c831-6fd0-4a58-9726-4e0f986c8084 | 2026-11-06 | Warnings | M007 |
| up and up fiber therapy | CALCIUM POLYCARBOPHIL | Target Corporation. | e5473950-06f4-4ea4-975b-3ac94957e776 | 2026-11-06 | Warnings | M007 |
| Target Fiber Laxative | PSYLLIUM HUSK | TARGET CORPORATION | a581116a-392d-4ac3-ae15-4318506a7b2a | 2026-11-05 | Warnings | M007 |
| up and up gentle laxative | BISACODYL | Target Corporation | 4a29dc2b-b68f-471b-a84e-4a5096aa3748 | 2026-11-05 | Warnings | M007 |
| Metamucil Therapy for regularity | PSYLLIUM HUSK | The Procter & Gamble Manufacturing Company | a9824f73-5ea2-4a65-a926-3a57561441b8 | 2026-11-04 | Warnings | M007 |
| Colon Detox | DOCUSATE SODIUM AND SENNOSIDES | OPMX LLC | 0a4d3265-080c-d2ed-e063-6394a90adbee | 2026-11-04 | Warnings | M007 |
| Glycerin | GLYCERIN | Beijing Jingfeng Pharmaceutical (Shandong) Co., Ltd | 552e16b9-f46a-7838-e063-6394a90ab8aa | 2026-11-04 | Warnings | M007 |
| Fiber Caplets | CALCIUM POLYCARBOPHIL | SAFEWAY | 08e2e8b0-90b3-48d6-a72a-40688c74771a | 2026-11-03 | Warnings | M007 |
| citroma | MAGNESIUM CITRATE | Old East Main Co. | 9b3b6cea-ab83-4b7c-a425-fd0ac7df426c | 2026-11-02 | Warnings, Adverse reactions | M007 |
| Gentle Laxative Stimulant Laxative | BISACODYL | QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) | bcd3c07d-bd83-4452-9736-35c85db30c15 | 2026-10-29 | Warnings | M007 |
| Quality Choice | CALCIUM POLYCARBOPHIL | QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) | f1e69c65-c1b0-459f-9a12-b1a92b90036b | 2026-10-29 | Warnings | M007 |
| CDMA Fiber Therapy | METHYLCELLULOSE | CHAIN DRUG MARKETING ASSOCIATION | 62bbcaf2-1d0c-485f-9159-685700aa3418 | 2026-10-29 | Warnings | M007 |
| citroma | MAGNESIUM CITRATE | Old East Main Co. | 51ed515b-cc51-4ea1-b612-090476135005 | 2026-10-29 | Warnings, Adverse reactions | M007 |
| Quality Choice Fiber Laxative | PSYLLIUM HUSK | QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) | 2ee637c4-c4c6-4a24-ae99-612205afd592 | 2026-10-29 | Warnings | M007 |
| Magnesium Citrate | EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - CHERRY | 4 Visions LLC | 5eeb0d66-06c7-7789-e063-6394a90aaff4 | 2026-10-28 | Warnings | M007 |
| Fiber Lax | CALCIUM POLYCARBOPHIL | PD-Rx Pharmaceuticals, Inc. | 730198a5-b6d9-4fc7-b053-a7c65a93c540 | 2026-10-27 | Warnings | M007 |
| Senna S | DOCUSATE SODIUM AND SENNOSIDES | Marlex Pharmaceuticals Inc | 9c87759f-3856-4f30-b5ea-4b37ed90f18c | 2026-10-27 | Warnings | M007 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 998740 | sennosides 8.6 MG / docusate sodium 50 MG Oral Tablet | PSN | 92879e62-f60a-4ab4-9532-610cdd2628ee | 5 |
| 998740 | docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet | SCD | 92879e62-f60a-4ab4-9532-610cdd2628ee | 5 |
| 998740 | DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet | SY | 92879e62-f60a-4ab4-9532-610cdd2628ee | 5 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 71205-282-90 | 71205028290 | 90 TABLET in 1 BOTTLE, PLASTIC (71205-282-90) | 90 tablet | 2019-06-01 | 0000-00-00 | No | No | Current |